Forum Home | Log in | Signup | My Page | Rules | FAQ | Boards | Members | Search
Replies to Msg. #1091772
.
 Msg. #  Subject Posted by    Board    Date   
46090 Re: Stock Tip: KPTI
   Decomposed  		 POPE 5   04 Dec 2019
 11:50 PM
43817 Re: Stock Tip: KPTI
   Decomposed  		 POPE 5   04 Nov 2019
 5:38 PM
43657 Re: Stock Tip: KPTI
   Decomposed  		 POPE 5   01 Nov 2019
 10:46 PM
39618 Re: Stock Tip: KPTI
   Decomposed  		 POPE 5   10 Sep 2019
 10:31 PM

The above list shows replies to the following message:

Stock Tip: KPTI

By: Decomposed in POPE 5
Fri, 05 Jul 19 8:47 PM
Msg. 35619 of 62138
Jump to msg. #  

IMO, Karyopharm Therapeutics is a screaming deal at $8.65/share. The company just received FDA approval on its multiple myeloma drug, XPOVIA, and the drug is coming to market in a week. That's almost unheard of.

The company has a small market cap ($400 million), which means that the approval should impact it in a big way. The drug price will be $22,000 per month. Consider the 200,000 Americans who contract the disease each year and that it is almost always fatal. Then do the obvious math (200,000 Americans buying xpovia at $264,000 per year, Angie) keeping in mind what the company's current market cap is and that many of the world's multiple myeloma sufferers will probably start buying it too at some point. That will tell you why I'm excited about KPTI.

There are risks: Competing drugs do exist. Not many, imo. The FDA has only approved xpovia for use on patients who have already gone through several other regimens. So, xpovia will likely be limited to patients who are in their final year of life. (Remember that all who contract the disease reach that point eventually.) And the FDA states that it may withdraw its approval if future tests do not support the drug's efficacy. Politically, high priced drugs may come under attack, especially if a Democrat wins the White House.

I took my position at $8.95, so it's now a bit cheaper. I don't care. I'm in it for the long haul.

I don't buy many stocks anymore, mostly because my interest is ONLY in small-cap pharmaceuticals that get FDA approval on an important, high priced drug. KPTI meets all of my criteria.


Avatar

Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months